Compare NXP Semiconductors N.V. Common Stock (NXPI) vs SELLAS Life Sciences Group Inc. Common Stock (SLS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
NXP Semiconductors N.V. Common Stock vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? NXP Semiconductors N.V. Common Stock trades at $226.04 (market cap $58.27B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.45 (market cap $2.27B). The key difference: NXP Semiconductors N.V. Common Stock is far larger — about 25.7× SELLAS Life Sciences Group Inc. Common Stock's market cap, and NXP Semiconductors N.V. Common Stock pays a 1.76% dividend while SELLAS Life Sciences Group Inc. Common Stock pays none. Which is the better fit depends on your goals.
| NXPI | SLS | |
|---|---|---|
Market Cap | $58.27B | $2.27B |
Volume | 3,950,702 | 4,179,659 |
Sector | Technology | Health |
52-Week High | $332.67 | $15.46 |
52-Week Low | $184.19 | $1.39 |
Typical Hold Time | 0 Days | — |
Enterprise Value | $66.38B | $2.14B |
Dividend Yield | 1.76% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About NXP Semiconductors N.V. Common Stock
NXP Semiconductors designs semiconductor solutions for embedded applications. Its products serve automotive, industrial and IoT, mobile, and communications-infrastructure markets.
Read more on NXPI →About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →
